Pagano et al reported that 4 to 6 weeks of metformin treatment caused a striking decrease in the insulin requirement of patients with type 1 diabetes (T1D) without inducing lactic acidosis (19), and subsequent studies showed that metformin effectively improved peripheral insulin sensitivity in both T1D and T2D patients (20, 21). This evidence concerns the gene INS and type 1 diabetes mellitus.